SRRK
SRRK
NASDAQ · Biotechnology

Scholar Rock Holding Corp

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$48.16
+1.51 (+3.24%)
As of Sep 21, 9:55 PM ET ·
SRRK News1 articles
Scholar Rock's Isembyld Approval Fuels Launch Test, Shares Slip
Scholar Rock's stock dropped 4.6% after FDA approval of Isembyld, its first drug for SMA. The focus shifts from regulatory approval to commercial launch execution.
Analysis